MX2009006243A - Potenciadores del receptor ampa. - Google Patents
Potenciadores del receptor ampa.Info
- Publication number
- MX2009006243A MX2009006243A MX2009006243A MX2009006243A MX2009006243A MX 2009006243 A MX2009006243 A MX 2009006243A MX 2009006243 A MX2009006243 A MX 2009006243A MX 2009006243 A MX2009006243 A MX 2009006243A MX 2009006243 A MX2009006243 A MX 2009006243A
- Authority
- MX
- Mexico
- Prior art keywords
- ampa receptor
- receptor potentiators
- potentiators
- psychiatric
- useful
- Prior art date
Links
- 102000003678 AMPA Receptors Human genes 0.000 title 1
- 108090000078 AMPA Receptors Proteins 0.000 title 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229930195712 glutamate Natural products 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06380319 | 2006-12-11 | ||
| US88856207P | 2007-02-07 | 2007-02-07 | |
| PCT/US2007/086567 WO2008073789A1 (en) | 2006-12-11 | 2007-12-06 | Ampa receptor potentiators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009006243A true MX2009006243A (es) | 2009-08-12 |
Family
ID=39272878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009006243A MX2009006243A (es) | 2006-12-11 | 2007-12-06 | Potenciadores del receptor ampa. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8097652B2 (enExample) |
| EP (1) | EP2102153A1 (enExample) |
| JP (1) | JP2010512339A (enExample) |
| KR (1) | KR20090082278A (enExample) |
| CN (1) | CN101541741A (enExample) |
| AU (1) | AU2007333247B2 (enExample) |
| CA (1) | CA2672462A1 (enExample) |
| EA (1) | EA015600B1 (enExample) |
| MX (1) | MX2009006243A (enExample) |
| WO (1) | WO2008073789A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012020848A1 (en) * | 2010-08-10 | 2012-02-16 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| US9527807B2 (en) | 2011-04-05 | 2016-12-27 | Takeda Pharmaceutical Company Limited | Sulfonamide derivative and use thereof |
| US20210009613A1 (en) * | 2017-12-12 | 2021-01-14 | Shenzhen Targetrx, Inc. | Arylphosphine oxides for inhibiting kinase activity |
| TWI873185B (zh) | 2019-09-16 | 2025-02-21 | 日商武田藥品工業股份有限公司 | 唑稠合之嗒-3(2h)-酮衍生物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702194D0 (en) * | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| BR0110874A (pt) * | 2000-05-19 | 2003-02-11 | Lilly Co Eli | Derivados de sulfonamida |
-
2007
- 2007-12-06 AU AU2007333247A patent/AU2007333247B2/en not_active Ceased
- 2007-12-06 KR KR1020097011988A patent/KR20090082278A/ko not_active Ceased
- 2007-12-06 MX MX2009006243A patent/MX2009006243A/es not_active Application Discontinuation
- 2007-12-06 WO PCT/US2007/086567 patent/WO2008073789A1/en not_active Ceased
- 2007-12-06 JP JP2009540465A patent/JP2010512339A/ja not_active Withdrawn
- 2007-12-06 CN CNA200780043800XA patent/CN101541741A/zh active Pending
- 2007-12-06 EP EP07854979A patent/EP2102153A1/en not_active Withdrawn
- 2007-12-06 EA EA200970573A patent/EA015600B1/ru not_active IP Right Cessation
- 2007-12-06 CA CA002672462A patent/CA2672462A1/en not_active Abandoned
- 2007-12-06 US US12/517,431 patent/US8097652B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101541741A (zh) | 2009-09-23 |
| US8097652B2 (en) | 2012-01-17 |
| AU2007333247B2 (en) | 2012-06-07 |
| AU2007333247A1 (en) | 2008-06-19 |
| EA200970573A1 (ru) | 2009-10-30 |
| US20100010090A1 (en) | 2010-01-14 |
| CA2672462A1 (en) | 2008-06-19 |
| EA015600B1 (ru) | 2011-10-31 |
| KR20090082278A (ko) | 2009-07-29 |
| EP2102153A1 (en) | 2009-09-23 |
| WO2008073789A1 (en) | 2008-06-19 |
| JP2010512339A (ja) | 2010-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200833686A (en) | Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| NO20070249L (no) | Pyrrazolo-pyrimidin derivater | |
| WO2007104783A3 (en) | 1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mglur2-recept0r modulators | |
| WO2007078523A3 (en) | 5-phenyl-3-benzyl-0xaz0lidin-2-0ne derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders | |
| WO2008060621A3 (en) | Aminopyrrolidines as chemokine receptor antagonists | |
| WO2009140166A3 (en) | Oxazolobenzimidazole derivatives | |
| UA106873C2 (uk) | Сполуки заміщених діазепанів як антагоністи орексинових рецепторів | |
| WO2007108936A3 (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
| MXPA05013474A (es) | Derivados de quinolilamida como antagonistas de ccr-5. | |
| WO2007062999A3 (en) | 1,5-substituted indol-2-yl amide derivatives | |
| WO2007136668A3 (en) | N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists | |
| PL1807434T3 (pl) | Tienopirydyny jako allosteryczne środki wzmacniające receptor M4 muskarynowy | |
| IL194057A0 (en) | Pyrimidine, quinazoline, pteridine and triazine derivatives | |
| MX2009006359A (es) | Derivados de aril sulfamida y metodos para su uso. | |
| TW200621739A (en) | Asymmetric synthesis of substituted dihydrobenzofurans | |
| WO2008131946A3 (de) | Substituierte amid-derivate | |
| WO2006123255A3 (en) | Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors | |
| AU2001274806A1 (en) | Sulfonamide derivatives | |
| MX2007011847A (es) | Derivados de pirimidindiona como antagonistas del receptor de procineticina 2. | |
| MY137272A (en) | Imidazole derivatives | |
| WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
| IL195747A0 (en) | Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity | |
| GB0513886D0 (en) | Novel compounds | |
| MXPA05012081A (es) | Derivados de pirimidina sustituidos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |